title: Annular leukocytoclastic vasculitis associated with sorafenib administration.
abstract: Only one case of vasculitis associated with sorafenib has been reported, and the authors now present the first reported case of annular leukocytoclastic vasculitis (LCV) linked to sorafenib administration.
authors.affiliation: Department of Dermatology, University of Medicine and Dentistry of New Jersey, Somerset, NJ 08873, USA. djn6uuu@gmail.com
authors.forename: David J
authors.initials: DJ
authors.lastname: Najarian
authors.forename: Vathani
authors.initials: V
authors.lastname: Packianathan
authors.forename: Nathalie C
authors.initials: NC
authors.lastname: Zeitouni
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001557:Benzenesulfonates / Q000009:adverse effects*; D006801:Humans; D008297:Male; D009536:Niacinamide / Q000031:analogs & derivatives; D010671:Phenylurea Compounds; D047428:Protein Kinase Inhibitors / Q000009:adverse effects*; D011725:Pyridines / Q000009:adverse effects*; D000077157:Sorafenib; D018366:Vasculitis, Leukocytoclastic, Cutaneous / Q000139:chemically induced*
chemical_list: D000970:Antineoplastic Agents; D001557:Benzenesulfonates; D010671:Phenylurea Compounds; D047428:Protein Kinase Inhibitors; D011725:Pyridines; D009536:Niacinamide; D000077157:Sorafenib